Roche
Manufacturing · Switzerland · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Grenzacherstrasse 124, Basel, Basel-City...Phone Number
+41 616881111Website
www.roche.comRevenue
$79.8 BillionStock Symbol
ROIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
32
2
4
3
3
2
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The compaRead more
Roche Org Chart
AH
Chief Financial Officer, Finance & Manager, R...
AM
Chief Financial Officer, & Caribbean (Central...
MN
Chief Financial Officer (Vietnam)
TH
Chief Financial Officer (China)
YY
Senior Financial Controller
SG
Financial Controller
RJ
Financial Controller
BV
Procurement Lead Financial Controller
CW
Finance Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Roche your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Roche launches new products
Congratulate Masked Content for being promoted to Masked Content at Roche
Roche, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Roche had a recent Job posting/layoffs
Check out if Roche is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Roche recently announced quarterly report
Funding: Get notified immidiatlly once Roche has new funding data
Check if Roche has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Roche
Find 2 more new buyers
Compare Similar Companies to Roche
Compare insights from companies similar to Roche, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Roche is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Roche is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Roche.
Roche Tech Stack
A closer look at the technologies used by Roche
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Roche News & Media
FDA grants Priority Review to Roche’s Enspryng, the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
Basel, 30 June 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License Application (sBLA) for Enspryng® (satralizumab) for the treatment of thyroid eye disease (TED). The filing acceptance is based on results from the two randomised, placebo-controlled global phase III SatraGO studies assessing the safety and efficacy of Enspryng in patients with moderate to severeRoche announces the launch of AXELIOS 1, a transformative next-generation sequencing platform
Basel, 29 June 2026 — Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today the launch of AXELIOS 1 based on the innovative SBX technology, with a unique combination of accuracy, speed, flexibility, scalability and cost efficiency that addresses critical bottlenecks in genomics and potentially in clinical research. AXELIOS 1 will enable researchers to make significant discoveries that enhance our understanding of diseases, with the potential to replace existing technologies in pivotal research areaFDA accepts supplemental Biologics License Application for Roche’s Lunsumio and Polivy combination for people with relapsed or refractory large B-cell lymphoma
Basel, June 18, 2026 - Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) for Lunsumio VELO™ (mosunetuzumab), as a subcutaneous formulation, in combination with Polivy® (polatuzumab vedotin) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma (LBCL), including diffuse large B-cell lymphoma (DLBCL), after at least one prior line of systemicLong Island Artist Ian James Roche Named Quarter Finalist in Johnny Depp's 2026 People's Artist Competition
COMMACK, NY, UNITED STATES, June 17, 2026 /EINPresswire.com/ -- Self-taught Long Island artist Ian James Roche, a longtime resident of Commack, Suffolk County, has been named a quarter finalist in the 2026 People's Artist Competition. The campaign is …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Roche
Sign Up For FreeTo access detailed company insights
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's p... Read More
